Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic
Atilla Soran, Michael L. Gimbel, Emilia J. Diego
Abstract
The COVID-19 Pandemic has not only changed our daily routines but also forced us to re-think the approach to cancer patients in these unprecedented times.Breast cancer is the most common cancer in women globally.It is unfortunate that there are subsets of those affected by COVID-19 who will experience more severe symptoms and are considered a vulnerable population: cancer patients fall into this category.Fortunately, developments in breast cancer diagnosis and treatment provide us with options such as neoadjuvant systemic therapy in the form of hormonal therapy, anti-HER2 or systemic chemotherapy and a variety of modifiable breast reconstruction strategies.
Topics & Concepts
PandemicBreast cancerMedicineCoronavirus disease 2019 (COVID-19)CancerHormonal therapySystemic therapyPopulationIntensive care medicineOncologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineDiseaseEnvironmental healthInfectious disease (medical specialty)COVID-19 and healthcare impacts